Lanzafame_1997_J.Pharmacol.Exp.Ther_282_278

Reference

Title : Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors - Lanzafame_1997_J.Pharmacol.Exp.Ther_282_278
Author(s) : Lanzafame A , Christopoulos A , Mitchelson F
Ref : Journal of Pharmacology & Experimental Therapeutics , 282 :278 , 1997
Abstract :

Functional studies were conducted on guinea pig atrial muscarinic acetylcholine M2 receptors with the allosteric modulators heptane-1,7-bis(dimethyl-3'-phthalimidopropyl)ammonium bromide (C7/3'-phth), gallamine and alcuronium to determine whether these ligands are able to recognize a common accessory site. The three modulators inhibited the negative inotropic response to carbachol in this tissue. When used in combination, C7/3'-phth and gallamine or C7/3'-phth and alcuronium gave dose ratios that were either additive or underadditive. In contrast, the combinations of C7/3'-phth or alcuronium with the competitive antagonists, N-methylscopolamine or atropine, yielded supra-additive dose ratios. The data could be reconciled with a model involving a ternary complex between (1) the receptor, (2) carbachol, N-methylscopolamine or atropine acting at the orthosteric binding site and (3) C7/3'-phth, alcuronium or gallamine acting at a common, allosteric site with varying degrees of heterotropic cooperativity.

PubMedSearch : Lanzafame_1997_J.Pharmacol.Exp.Ther_282_278
PubMedID: 9223565

Related information

Citations formats

Lanzafame A, Christopoulos A, Mitchelson F (1997)
Three allosteric modulators act at a common site, distinct from that of competitive antagonists, at muscarinic acetylcholine M2 receptors
Journal of Pharmacology & Experimental Therapeutics 282 :278

Lanzafame A, Christopoulos A, Mitchelson F (1997)
Journal of Pharmacology & Experimental Therapeutics 282 :278